St. Anna Children's Cancer Research Institute (CCRI)
Karin Hartl-Schmitzer has a diverse work experience in various HR roles. Karin is currently the Head of HR at St. Anna Kinderkrebsforschung (Children's Cancer Research Institute - CCRI) since 2022. Prior to that, they served as the HR Director at Beyond Now, a digital platform provider, from 2020 to 2022. Before that, they were the Leitung Human Resources at CERHA HEMPEL from 2018 to 2020 and the Manager Human Resources at Konica Minolta Business Solutions Austria GmbH from 2016 to 2018. Additionally, they held different positions at ANECON Software Design und Beratung GmbH, including Director Management Services, Leiterin Finance & HR, and Leiterin Human Resources, from 2012 to 2016. Karin also worked as an Organization & Staffing Expert at Telekom Austria Group from 2010 to 2012 and as an Expert Group HR Development at mobilkom austria group services GmbH from 2008 to 2010. Karin began their career at mobilkom austria as a Mitarbeiter HR Expertise Center from 2001 to 2007.
Karin Hartl-Schmitzer is currently pursuing a Strategic Human Resources Leadership Certificate from Cornell University, with an expected completion date in 2022. Prior to this, they attended WU (Vienna University of Economics and Business) from 2000 to 2007, where they obtained a Mag. degree in Betriebswirtschaft.
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).